drugset / Trial / NCT01713556

Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial

NCT01713556 ↗

Phase 2 Completed 87 enrolled University Hospital, Toulouse
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to test whether propranolol, when given during a re-evocation of a traumatic memory, is capable of reducing subsequent PTSD symptoms associated with that memory.

Timeline

Start
2012-11
Primary completion
2017-05
Completion
2017-06-30

Outcome

Missed primary endpoint

paper However, the efficacy of propranolol was not greater than that of placebo 1 week post treatment. PMID 33612830 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule — —